More than half of American adults have raised, discolored veins that produce swelling in the ankle, along with sore, achy legs. These are called varicose veins, and left untreated, they can lead to more serious health problems.
In 2018, we welcomed several internationally renowned physicians to the Department of Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. These men and women are leaders in their respective fields. They have a track record of innovation and their collaborative multidisciplinary team approach allows them to provide the very highest level of patient care. While these surgeons spearhead the newest treatments and techniques, they are also very compassionate communicators.
Virendra (V) Patel, MD, MPH, a national expert in the field of vascular surgery, has joined NYP/Columbia as Chief of Vascular Surgery and Co-director of The Aortic Program. He was also named Associate Professor of Surgery at Columbia University Medical Center.
Columbia Doctors Non-Invasive Vascular Laboratory has earned accreditation from the IAC (Intersocietal Accreditation Commission) on Vascular Testing. IAC accreditation is also given to medical centers dedicated to continuous advancement in this field.
Gary Tannenbaum, MD, RVT, FACS, Chief of Vascular and Endovascular Surgery at NewYork-Presbyterian/Lawrence Hospital in Bronxville, NY, now offers a full range of services in Southern Westchester country.
PAD now affects more than 8.5 Americans and is becoming more prevalent as the population ages--yet this condition often goes undiagnosed. Patients with peripheral arterial disease have a higher risk of coronary artery disease, heart attack or stroke. Left untreated, PAD can lead to gangrene and amputation.
NYP/Morgan Stanley Children’s Hospital has one of the top programs in the nation for the diagnosis and treatment of pediatric vascular anomalies. The Vascular Anomalies Group evaluates patients with a variety of vascular tumors, malformations, and associated syndromes including the newly categorized PIK3CA-related overgrowth spectrum (PROS), formerly labeled overgrowth syndromes.
